Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Acadia Pharmaceuticals

Acadia Pharmaceuticals reported $-43021000 in Net Income for its fiscal quarter ending in March of 2023.

Net Income Change
Acadia Pharmaceuticals ACAD:US USD -43021000 1.3M
ALKERMES ALKS:US USD -41845000 13.59M
Alnylam Pharmaceuticals ALNY:US USD -174101000 33.39M
Biogen BIIB:US USD 387.9M 162.5M
BioMarin Pharmaceutical BMRN:US USD 50.85M 51.1M
Bristol-Myers Squibb BMY:US USD 2.26B 240M
Cara Therapeutics CARA:US USD -26665000 3.67M
Eisai 4523:JP JPY 16.32B 7.68B
Eli Lilly LLY:US USD 1.34B 592.8M
Incyte Corp INCY:US USD 21.7M 6.76M
Intercept Pharmaceuticals ICPT:US USD -32135000 11.31M
Intra Cellular Therapies ITCI:US USD -44053000 27K
J&J JNJ:US USD -68000000 3.59B
Marinus Pharmaceuticals MRNS:US USD -34730000 418K
Moderna Inc MRNA:US USD 79M 1.39B
Neurocrine Biosciences NBIX:US USD -76600000 165.6M
Pfizer PFE:US USD 5.54B 548M
PTC Therapeutics PTCT:US USD -138959000 31.93M
Sarepta Therapeutics SRPT:US USD -516755000 407.51M
Seattle Genetics SGEN:US USD -174737000 26.57M
Ultragenyx Pharmaceutical RARE:US USD -163972000 12.14M
Vertex Pharmaceuticals VRTX:US USD 699.8M 119.1M